SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-17-000017
Filing Date
2017-08-10
Accepted
2017-08-10 17:18:06
Documents
42
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myovant10q63017.htm 10-Q 737427
2 EXHIBIT 31.1 myovantex31163017.htm EX-31.1 9448
3 EXHIBIT 31.2 myovantex31263017.htm EX-31.2 9566
4 EXHIBIT 32.1 myovantex32163017.htm EX-32.1 6251
5 EXHIBIT 32.2 myovantex32263017.htm EX-32.2 5942
  Complete submission text file 0001679082-17-000017.txt   2154353

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20170630.xml EX-101.INS 166258
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20170630.xsd EX-101.SCH 19867
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20170630_cal.xml EX-101.CAL 40205
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20170630_def.xml EX-101.DEF 74790
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20170630_lab.xml EX-101.LAB 268950
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20170630_pre.xml EX-101.PRE 151328
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 171022294
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences